RHEACELL announced today that it has entered into an exclusive partnership agreement with the AOP Health Group, who will ...

Oral presentation of clinical data from FT819 Phase 1 study highlights safety and efficacy of fludarabine-free treatment ...

The US FDA has granted regenerative medicine advanced therapy (RMAT) designation to AbelZeta Pharma’s C-CAR168.

The FDA urges health care professionals and consumers to report any adverse events related to treatments with Liveyon products, Genetech products or other stem cell treatments to its MedWatch ...

DUBLIN, Ohio, May 7, 2025 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) released its 2025 Advanced Therapies Report: Revolutionizing patient care – the promise and potential of cell and ...